Clinical Trials Directory

Trials / Completed

CompletedNCT04394520

Use of Consent Language and Mode to Improve Interactive Voice Response Survey in Colombia and Uganda

A Randomized Controlled Trial of Varying Consent Language and Mode to Improve Interactive Voice Response (IVR) Survey Performance in Colombia and Uganda

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
3,786 (actual)
Sponsor
Johns Hopkins Bloomberg School of Public Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the effect of one new form of introduction language and three new modes of providing consent on interactive voice response (IVR) survey cooperation, response, refusal and contact rates, as compared to control group, in Colombia and Uganda.

Detailed description

Using random digit dialing (RDD) sampling technique, RDD participants will be randomized to one of five introduction and consent combinations and then have them complete noncommunicable disease risk factor survey with an additional module regarding their understanding of the survey and of its voluntariness. This mobile phone survey will be sent as an interactive voice response (IVR). In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study will be conducted in both Colombia and Uganda.

Conditions

Interventions

TypeNameDescription
OTHERModified IntroductionA variation in the introductory content to motivate participants to complete the survey. Participants will be presented with modified introductory language based on the findings from local focus groups and key informant interviews.
OTHERActive Opt-inA variation in the consent mode to motivate participants to complete the survey. Participants will be given the choice to actively opt-in to the survey, if they do not respond, the survey will terminate.
OTHERActive Opt-outA variation in the consent mode to motivate participants to complete the survey. Participants will be given the choice to actively opt-out to the survey, if they do not respond, the survey will continue.
OTHERPassive Opt-inA variation in the consent mode to motivate participants to complete the survey. Participants will be given the choice to passively opt-in to the survey, if they do not hang-up, the survey will continue.

Timeline

Start date
2018-08-31
Primary completion
2019-01-05
Completion
2019-01-05
First posted
2020-05-19
Last updated
2020-05-19

Locations

2 sites across 2 countries: Colombia, Uganda

Source: ClinicalTrials.gov record NCT04394520. Inclusion in this directory is not an endorsement.